Shares in Fresenius Medical Care are seen dropping 5.7 percent to the bottom of Germany’s blue-chip index, according to pre-market data, after it unexpectedly forecast another decline in profit this year amid U.S. healthcare budget cuts.
“Although the guidance does not include potential pre-tax cost savings... the outlook is clearly disappointing,” DZ Bank analyst Sven Kuerten says.
FMC says its 2014 net profit will be between $1 billion and $1.05 billion, down from $1.11 billion last year and below analysts’ consensus forecast of $1.19 billion in a Reuters poll.
Shares in Fresenius, which controls FMC, are seen down 3.2 percent.
Reuters messaging rm://email@example.com